Ketamine vs. TMS vs. Spravato: How Our Parsippany, NJ Team Helps You Choose

If you’ve reached the point where your doctor is discussing TMS, Spravato, or ketamine, you’re likely dealing with depression that hasn’t responded to standard treatments. These are all legitimate, evidence-supported options — but they work differently, cost differently, and fit different clinical situations. Here’s an honest comparison to help you and your provider think it through.

The Advanced Treatment Decision Point

For patients in Parsippany, Lake Hiawatha, Mountain Lakes, Denville, Morristown, Rockaway, Wayne, Randolph, and throughout Morris County who have tried multiple antidepressants without adequate relief, the conversation eventually arrives at a set of treatments that feel categorically different from what came before. Ketamine infusions, transcranial magnetic stimulation (TMS), and esketamine (Spravato) are all evidence-supported interventions for treatment-resistant depression. None of them is a pill you take at home. All of them require clinical administration and monitoring.

The fact that they share this general territory doesn’t mean they are interchangeable. Understanding how they differ — in mechanism, administration, evidence base, cost, and clinical fit — is essential to making a good decision. This article provides that comparison, honestly and without advocating for the option we happen to offer.

How Each Treatment Works

Intravenous (IV) Ketamine

IV ketamine works primarily by blocking NMDA receptors in the brain — a mechanism that acts on the glutamate system rather than the serotonin or dopamine systems targeted by conventional antidepressants. This distinct mechanism is the primary reason ketamine can reach patients for whom standard medications have failed. The rapid onset of effect — hours to days rather than weeks — is a feature of the glutamate pathway that is not replicated by any other current antidepressant approach.

IV ketamine is administered as a slow intravenous infusion over 40 to 60 minutes, in a supervised clinical setting with continuous vital sign monitoring. A standard induction course consists of six sessions over two to three weeks. It is used off-label for psychiatric indications — meaning it is prescribed based on clinical evidence and physician judgment, outside its FDA-approved indication as an anesthetic.

Spravato (Esketamine Nasal Spray)

Spravato is esketamine — a specific molecular version (enantiomer) of ketamine — reformulated as a nasal spray. It was FDA-approved in 2019 specifically for treatment-resistant depression and, subsequently, for major depressive disorder with suicidal ideation. Because of this FDA approval, Spravato is covered by many insurance plans under specific criteria — a meaningful practical difference from IV ketamine, which is almost universally out-of-pocket for psychiatric indications.

Spravato must be administered in a certified healthcare setting — you cannot take it home. Patients self-administer the nasal spray at the clinic and are then monitored for at least two hours for dissociation, blood pressure changes, and other effects before discharge. The treatment schedule involves twice-weekly sessions for the first month, then weekly, then less frequently based on response.

Spravato and IV ketamine target similar mechanisms and produce broadly similar effects, but they are not identical — the specific molecular form, the route of administration, and the blood levels achieved differ between the two. Some patients respond to one and not the other; some clinicians have strong preferences based on patient profile and clinical experience.

TMS (Transcranial Magnetic Stimulation)

TMS works through an entirely different mechanism than either form of ketamine. Rather than administering a drug, TMS uses a magnetic coil placed against the scalp to deliver targeted magnetic pulses to specific brain regions — most commonly the dorsolateral prefrontal cortex, an area associated with mood regulation that shows reduced activity in depressed patients.

TMS is non-invasive and drug-free. It does not involve anesthesia, IV access, or systemic drug effects. Most patients experience no significant side effects beyond mild scalp discomfort or headache during sessions. It does not carry the dissociative experience of ketamine, does not affect blood pressure, and does not require the same level of clinical monitoring during administration.

A standard TMS course for depression typically involves daily sessions (Monday through Friday) for six weeks — a more intensive scheduling commitment than ketamine but with sessions that typically last only 20 to 40 minutes. TMS is FDA-approved for depression and is covered by many insurance plans when specific medical necessity criteria are met.

Side-by-Side Comparison

“None of these treatments is universally superior. The right choice depends on your specific diagnosis, your medical history, your insurance situation, how quickly you need relief, and factors that only emerge through a proper clinical evaluation.”

Which Patients Tend to Do Better With Each Option?

IV Ketamine May Be Preferable When:

• Speed of response is clinically urgent — ketamine’s hours-to-days onset is faster than TMS and roughly comparable to Spravato
• You have treatment-resistant depression and a chronic pain condition — ketamine has established evidence for both, while Spravato and TMS do not have comparable pain indications
• You have tried Spravato without adequate response, or Spravato is not available in your area
• Insurance coverage is not available for any of the three options, and you are paying out-of-pocket — IV ketamine may offer a more flexible and in some cases more affordable course compared to Spravato’s longer-term administration schedule

Spravato May Be Preferable When:

• Insurance coverage is a priority — Spravato’s FDA approval makes insurance coverage significantly more likely than for IV ketamine
• You have a diagnosis of major depressive disorder with suicidal ideation, which is one of Spravato’s specific FDA-approved indications
• You prefer a nasal spray administration to an IV infusion, and the two-hour monitoring period is manageable

TMS May Be Preferable When:

• You want to avoid the dissociative experience of ketamine entirely
• You have medical conditions that contraindicate ketamine (uncontrolled hypertension, history of psychosis, etc.) but no contraindications to magnetic stimulation
• Insurance coverage is available and the six-week daily schedule is manageable
• You have not tried TMS before, and your provider recommends it as a next step before ketamine
• Speed of response is less critical — you can afford to wait the several weeks that TMS typically requires to show effect

Can These Treatments Be Combined?

In some cases, yes. TMS and ketamine are sometimes used sequentially — a course of TMS followed by ketamine (or vice versa) for patients who partially respond to one or respond to one but lose the benefit over time. Spravato and psychotherapy are explicitly designed to be used together in Spravato’s approved protocol. Ketamine and therapy are similarly synergistic.

Combining these treatments simultaneously without clear clinical rationale is less common and requires careful coordination between providers. If you are interested in a combination approach, this is a conversation to have directly with your treatment team — not a decision to make based on general information.

How Our Parsippany Team Helps You Decide

At North Jersey Interventional Pain Center, we offer ketamine infusion therapy — we do not offer TMS or Spravato directly. But we believe our job is to help you make the best decision for your situation, even when that might mean a different provider or a different treatment.

During your consultation, our team will review your clinical history, the treatments you’ve already tried, your insurance situation, your preferences, and the relevant evidence — and give you our honest assessment of where ketamine fits in your treatment picture. For patients in Morristown, Denville, Rockaway, Lake Hiawatha, Wayne, Randolph, Boonton, Towaco, and throughout Morris County who may be weighing all three options, we can help you think through the comparison and coordinate with other providers if needed.

Frequently Asked Questions

Is Spravato the same as ketamine?

Spravato (esketamine) is derived from ketamine and works on the same glutamate pathway, but it is not identical. Esketamine is a specific molecular form (S-enantiomer) of ketamine, delivered as a nasal spray rather than by IV. The clinical effects are broadly similar — including the dissociative experience — but the pharmacokinetics, the dosing protocol, and the regulatory status differ. Some patients respond to one and not the other.

Does TMS work as quickly as ketamine?

No. TMS typically requires several weeks of daily sessions before meaningful improvement is seen — a timeline similar to conventional antidepressants. Ketamine and Spravato can produce effects within hours to days. For patients in acute clinical need, this difference in speed of onset can be significant.

If I try ketamine and it doesn’t work, can I still try TMS or Spravato afterward?

Generally yes. A ketamine non-response does not typically preclude trying other advanced treatments. The mechanisms are different enough that non-response to one does not reliably predict non-response to another. Your treatment team should guide sequencing decisions based on your specific clinical history.

Can my insurance cover ketamine if it covers Spravato?

Not automatically. Insurance coverage for Spravato and IV ketamine is governed by separate coverage determinations. Spravato’s FDA approval makes it categorically easier to get covered; IV ketamine’s off-label status for psychiatric indications means most insurers do not cover it regardless of whether they cover Spravato. Always verify directly with your insurer — and see our post on ketamine therapy cost and insurance in North Jersey for more detail.

Medical Disclaimer: This article is for general educational purposes only and does not constitute medical advice. Treatment comparisons are intended to be informational, not prescriptive. The right treatment for any individual patient depends on clinical factors that require professional evaluation. North Jersey Interventional Pain Center offers ketamine infusion therapy; references to TMS and Spravato are for educational comparison only. Always consult a qualified healthcare professional before making treatment decisions.